Identification of KRAS G12V associated clonal neoantigens and immune microenvironment in long-term survival of pancreatic adenocarcinoma
Authors:
Open Access
- 13 July 2021
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 71 (2) , 491-504
Abstract
Objective: To investigate the molecular characteristics in tumor immune microenvironment that affect long-term survival of patients with pancreatic adenocarcinoma (PAAD). Methods: The tumor related genetic features of a female PAAD patient (over 13-year survival) who suffered from multiple recurrences and metastases, and six operations over one decade were investigated deeply. Genomic features and immune microenvironment signatures of her primary lesion as well as six metastatic tumors at different time-points were characterized. Results: High-frequency clonal neoantigenic mutations identified in these specimens revealed the significant associations between clonal neoantigens with her prognosis after each surgery. Meanwhile, the TCGA and ICGC databases were employed to analyse the function of KRAS G12V in pancreatic cancer. Conclusions: The genomic analysis of clonal neoantigens combined with tumor immune microenvironment could promote the understandings of personalized prognostic evaluation and the stratification of resected PAAD individuals with better outcome.Keywords
Funding Information
- National Natural Science Foundation of China (81972707 and 81672327)
- Development Grant for Clinical Trial (SHDC12017X06)
- Shanghai Rising-Star Program (20QA1406200)
- Shanghai Municipal Population and Family Planning Commission (20184Y0048)
- Guangci Distinguished Young Scholars Training Program (GCQN-2018-A06)
- Doctoral Innovation Fund Projects from Shanghai Jiaotong University School of Medicine (BXJ201915)
- National Key Sci-Tech Special Project of China (2018ZX10302207)
This publication has 41 references indexed in Scilit:
- Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal AdenocarcinomaGastroenterology, 2018
- Evolution of Metastases in Space and Time under Immune SelectionCell, 2018
- Ovarian cancer statistics, 2018CA: A Cancer Journal for Clinicians, 2018
- Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal AdenocarcinomaJAMA Oncology, 2018
- Identification of unique neoantigen qualities in long-term survivors of pancreatic cancerNature, 2017
- Characteristics of 10-Year Survivors of Pancreatic Ductal AdenocarcinomaJAMA Surgery, 2015
- Very Long-term Survival Following Resection for Pancreatic Cancer Is Not Explained by Commonly Mutated Genes: Results of Whole-Exome Sequencing AnalysisClinical Cancer Research, 2015
- Pancreatectomy Predicts Improved Survival for Pancreatic AdenocarcinomaAnnals of Surgery, 2015
- Oncotator: Cancer Variant Annotation ToolHuman Mutation, 2015
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samplesNature Biotechnology, 2013